The questions submitted by the advocates follow:
ABRAMS: You are right that we do not want to see trials that a lot of time and effort has been put into, and patients have joined, and then don't meet their enrollment goals. We have to do more, and we've recognized that.
ABRAMS: OK, so I understand a little bit differently what you intended now.
NCI officials said they plan to hold a series of meetings with clinical trials group chairs and group financial officers in order to fine-tune the new National Clinical Trials Network.
FDA approved the cobas HPV test for women 25 and older that can be used alone to help a health care professional assess the need for a woman to undergo additional diagnostic testing for cervical cancer. The test also can provide information about the patient's risk for developing cervical cancer in the future.
The American Society of Clinical Oncology published three clinical practice guidelines for the prevention and management of neuropathy, fatigue, depression, and anxiety.
The Securities and Exchange Commission earlier this week said it has settled insider-trading charges against a prominent cancer researcher who was also an executive of a now-defunct company. Loretta Itri was charged with passing information about negative results of a cancer clinical trial to a longtime friend, who then passed the tip on to his... […]
The Case of Kapil MehtaBefore his tenure ran out, Mehta sought to change DePinho's mind. He appealed the decision, and a second independent committee, the Faculty Appeals Panel, supported the PTC recommendation.
The Presidential Veto Within two years, DePinho had vetoed more tenure renewals than the previous president, John Mendelsohn, had in seven. Recent denials of tenure in cases where applicants received unanimous recommendations from the PTC prompted the Executive Committee of the Faculty Senate to investigate the renewal process. “There has been some concern that the... […]
A year before Kapil Mehta's tenure term expired last August, the 11-member Promotions and Tenure Committee at MD Anderson Cancer Center had unanimously recommended renewal.
